Pfizer and BioNtech came out with promising results on their Phase 2/3 study for the vaccine for children between ages 5 and 11.
According to a press release on Sept. 20, the trial showed “robust...
On Aug. 23, the Food and Drug Administration finally approved the Pfizer-BioNTech COVID-19 vaccine, eight months after the vaccine became available to the public under emergency use authorization, paving...
The Guilfordian intends for this area to be used to foster healthy, thought-provoking discussion. Comments are expected to adhere to our standards and to be respectful and constructive. As such, we do not permit the use of profanity, foul language, personal attacks, or the use of language that might be interpreted as libelous. Comments are reviewed and must be approved by a moderator to ensure that they meet these standards. The Guilfordian does not allow anonymous comments, and requires a valid email address. The email address will not be displayed but will be used to confirm your comments.
